Evaluation of topical α-2 agonist in the treatment of mixed diabetic maculopathy

Evaluation of topical α-2 agonist in the treatment of mixed diabetic maculopathy

Purpose To evaluate the efficacy of topical α-2 agonist (brimonidine) in the treatment of mixed diabetic maculopathy (with edema and ischemia). Design This is a prospective randomized case series. Patients and methods Thirty eyes of 30 patients were included in this study. All eyes had mixed diabeti...

Full description

Bibliographic Details
Main Authors: Basem M Ibrahim, Haitham Y Al-Nashar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Delta Journal of Ophthalmology
Subjects:
α-agonist
brimonidine
diabetes
ischemic maculopathy
macular edema
Online Access:http://www.djo.eg.net/article.asp?issn=1110-9173;year=2018;volume=19;issue=2;spage=134;epage=139;aulast=Ibrahim

Internet

http://www.djo.eg.net/article.asp?issn=1110-9173;year=2018;volume=19;issue=2;spage=134;epage=139;aulast=Ibrahim

Similar Items